Analyst firms · Needham · TDOC
Needham TDOC price target and rating history
Teladoc Health Inc. (TDOC) · Health Care
Needham rates Teladoc Health Inc. (TDOC) Hold with a $100 price target, as of its latest action on Jul 28, 2022. It has published 4 rating actions on TDOC since July 2021, including 0 upgrades and 1 downgrade. Across 4 firms with a TDOC price target in the last 12 months, the median target is $8.25.
- Current rating
- Hold
- Price target
- $100
- Median target, all firms
- $8.25
- Actions on TDOC
- 4
Needham price target on TDOC
Every Needham rating on TDOC
- Jul 28, 2022DowngradeNeedham downgrades to Hold from Buy
- Feb 23, 2022
- Oct 28, 2021
- Jul 28, 2021
How other firms rate TDOC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Sell | Nov 2, 2026 | |
| Deutsche Bank | Buy | $11 | Mar 10, 2026 |
| BofA Securities | Buy | $7 | Feb 26, 2026 |
| Barclays | Equal Weight | $8.50 | Dec 9, 2025 |
| BMO Capital Markets | Market Perform | $8 | Nov 13, 2025 |
Questions about Needham and TDOC
- What is Needham's price target for TDOC?
- Needham's latest stated price target for Teladoc Health Inc. (TDOC) is $100, from its action on Feb 23, 2022.
- What is Needham's rating on TDOC?
- Needham rates TDOC Hold, a neutral rating, as of Jul 28, 2022.
- When did Needham last change its view on TDOC?
- On Jul 28, 2022, Needham downgrades to Hold from Buy.
- How does Needham's TDOC target compare with other analysts?
- Across 4 firms with a TDOC price target in the last 12 months, the median target is $8.25.
More TDOC rating histories
- Argus Research4
- Deutsche Bank4
- BofA Securities4
- Barclays4
- Goldman Sachs4
- Jefferies3
- Leerink Partners7
- Guggenheim4
- KeyBanc Capital Markets3
- Wells Fargo3
- Citigroup3
- Credit Suisse4
- Piper Sandler3
- Oppenheimer4
All Needham ratingsTDOC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.